Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling

被引:0
作者
Consuelo Gajate
Faustino Mollinedo
机构
[1] CSIC-Universidad de Salamanca,Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer
[2] Hospital Universitario de Salamanca,Instituto de Investigación Biomédica de Salamanca (IBSAL)
来源
Apoptosis | 2015年 / 20卷
关键词
Lipid rafts; CD95; Fas; Apoptotic signaling; Death receptor;
D O I
暂无
中图分类号
学科分类号
摘要
Membrane lipid rafts are highly ordered membrane domains enriched in cholesterol, sphingolipids and gangliosides that have the property to segregate and concentrate proteins. Lipid and protein composition of lipid rafts differs from that of the surrounding membrane, thus providing sorting platforms and hubs for signal transduction molecules, including CD95 death receptor-mediated signaling. CD95 can be recruited to rafts in a reversible way through S-palmitoylation following activation of cells with its physiological cognate ligand as well as with a wide variety of inducers, including several antitumor drugs through ligand-independent intracellular mechanisms. CD95 translocation to rafts can be modulated pharmacologically, thus becoming a target for the treatment of apoptosis-defective diseases, such as cancer. CD95-mediated signaling largely depends on protein–protein interactions, and the recruitment and concentration of CD95 and distinct downstream apoptotic molecules in membrane raft domains, forming raft-based supramolecular entities that act as hubs for apoptotic signaling molecules, favors the generation and amplification of apoptotic signals. Efficient CD95-mediated apoptosis involves CD95 and raft internalization, as well as the involvement of different subcellular organelles. In this review, we briefly summarize and discuss the involvement of lipid rafts in the regulation of CD95-mediated apoptosis that may provide a new avenue for cancer therapy.
引用
收藏
页码:584 / 606
页数:22
相关论文
共 933 条
  • [1] Joliot A(2004)Transduction peptides: from technology to physiology Nat Cell Biol 6 189-196
  • [2] Prochiantz A(2012)Cell-penetrating peptides: breaking through to the other side Trends Mol Med 18 385-393
  • [3] Koren E(2013)Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587 1693-1702
  • [4] Torchilin VP(2014)Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery J Control Release 174 126-136
  • [5] Bechara C(2014)Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules Peptides 57 78-94
  • [6] Sagan S(2003)Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J Biol Chem 278 585-590
  • [7] Wang F(2010)Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake J Control Release 147 171-179
  • [8] Wang Y(2009)Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate Biochim Biophys Acta 1788 2509-2517
  • [9] Zhang X(2000)Lipid rafts and signal transduction Nat Rev Mol Cell Biol 1 31-39
  • [10] Zhang W(2001)Roles of lipid rafts in membrane transport Curr Opin Cell Biol 13 470-477